Ionis to Hold Second Quarter 2024 Financial Results Webcast
Ionis to Hold Second Quarter 2024 Financial Results Webcast
Webcast scheduled for Thursday, August 1 at 11:30 a.m. Eastern Time
網絡直播預定於美國東部時間8月1日上午11:30進行
CARLSBAD, Calif., July 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Thursday, August 1st at 11:30 a.m. Eastern Time to discuss its second quarter 2024 financial results.
加州卡爾斯巴德，2024年7月19日 /美通社/ -- Ionis製藥公司（納斯達克：IONS）今天宣佈，將於美國東部時間8月1日上午11:30舉行現場網絡直播，討論其2024年第二季度財務業績。
The webcast may be accessed at . A replay will be available for a limited time at the same address.
可通過下面鏈接訪問網絡直播。重播地址同樣有效，但時間有限。
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.
關於Ionis Pharmaceuticals，Inc.
三十年來，Ionis一直致力於發明能爲重症患者帶來更美好未來的藥物。Ionis目前擁有五種上市藥品，以及神經病學、心臟病學和其他高患者需求領域的領先管線。作爲RNA靶向藥物的先驅，Ionis在RNA療法方面持續推動創新並推進基因編輯的新方法。對疾病生物學的深入理解和行業領先的技術推動我們的工作，加上爲患者提供改變生命的進展的熱情和緊迫感。欲了解更多關於Ionis的信息，請訪問Ionis.com並關注我們的推特和領英。
Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – [email protected] – 760-603-2331
Ionis製藥投資者聯繫方式：
D. Wade Walke, Ph.D. – [email protected] – 760-603-2331
Ionis Pharmaceuticals Media Contact:
Hayley Soffer – [email protected] – 760-603-4679
Ionis製藥媒體聯繫人：
Hayley Soffer – [email protected] – 760-603-4679
SOURCE Ionis Pharmaceuticals, Inc.
資料來源：Ionis Pharmaceuticals, Inc.